Exclusive: CVC and Temasek to buy generics firm Alvogen, Alvogen's CEO says
June 22, 2015 at 02:56 AM EDT
LONDON (Reuters) - European private equity fund CVC and Singaporean sovereign wealth fund Temasek [TEM.UL] are to buy a controlling stake in the pharmaceutical firm Alvogen, its chairman and chief executive said.
